These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23524187)

  • 1. Immune system targeting by biodegradable nanoparticles for cancer vaccines.
    Silva JM; Videira M; Gaspar R; Préat V; Florindo HF
    J Control Release; 2013 Jun; 168(2):179-99. PubMed ID: 23524187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting dendritic cells with nano-particulate PLGA cancer vaccine formulations.
    Hamdy S; Haddadi A; Hung RW; Lavasanifar A
    Adv Drug Deliv Rev; 2011 Sep; 63(10-11):943-55. PubMed ID: 21679733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses.
    Rosalia RA; Cruz LJ; van Duikeren S; Tromp AT; Silva AL; Jiskoot W; de Gruijl T; Löwik C; Oostendorp J; van der Burg SH; Ossendorp F
    Biomaterials; 2015 Feb; 40():88-97. PubMed ID: 25465442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of biodegradable nanoparticles as antigen delivery system.
    Petrizzo A; Conte C; Tagliamonte M; Napolitano M; Bifulco K; Carriero V; De Stradis A; Tornesello ML; Buonaguro FM; Quaglia F; Buonaguro L
    J Exp Clin Cancer Res; 2015 Oct; 34():114. PubMed ID: 26444005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo delivery of peptides and Toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model.
    Silva JM; Zupancic E; Vandermeulen G; Oliveira VG; Salgado A; Videira M; Gaspar M; Graca L; Préat V; Florindo HF
    J Control Release; 2015 Jan; 198():91-103. PubMed ID: 25483429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable nanoparticle mediated antigen delivery to human cord blood derived dendritic cells for induction of primary T cell responses.
    Diwan M; Elamanchili P; Lane H; Gainer A; Samuel J
    J Drug Target; 2003; 11(8-10):495-507. PubMed ID: 15203918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of PEG chain length and targeting moiety on antibody-mediated delivery of nanoparticle vaccines to human dendritic cells.
    Cruz LJ; Tacken PJ; Fokkink R; Figdor CG
    Biomaterials; 2011 Oct; 32(28):6791-803. PubMed ID: 21724247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles.
    Hamdy S; Elamanchili P; Alshamsan A; Molavi O; Satou T; Samuel J
    J Biomed Mater Res A; 2007 Jun; 81(3):652-62. PubMed ID: 17187395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced anti-tumor immune responses and delay of tumor development in human epidermal growth factor receptor 2 mice immunized with an immunostimulatory peptide in poly(D,L-lactic-co-glycolic) acid nanoparticles.
    Campbell DF; Saenz R; Bharati IS; Seible D; Zhang L; Esener S; Messmer B; Larsson M; Messmer D
    Breast Cancer Res; 2015 Mar; 17(1):48. PubMed ID: 25882711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology-based manipulation of dendritic cells for enhanced immunotherapy strategies.
    Klippstein R; Pozo D
    Nanomedicine; 2010 Aug; 6(4):523-9. PubMed ID: 20085824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of calcium phosphate nanoparticles encapsulating Toll-like receptor ligands and the antigen hemagglutinin to induce dendritic cell maturation and T cell activation.
    Sokolova V; Knuschke T; Kovtun A; Buer J; Epple M; Westendorf AM
    Biomaterials; 2010 Jul; 31(21):5627-33. PubMed ID: 20417963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
    Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of gene expression related to Toll-like receptor signaling in dendritic cells by poly(gamma-glutamic acid) nanoparticles.
    Hamasaki T; Uto T; Akagi T; Akashi M; Baba M
    Clin Vaccine Immunol; 2010 May; 17(5):748-56. PubMed ID: 20219877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells.
    Elamanchili P; Diwan M; Cao M; Samuel J
    Vaccine; 2004 Jun; 22(19):2406-12. PubMed ID: 15193402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.
    Kokate RA; Chaudhary P; Sun X; Thamake SI; Maji S; Chib R; Vishwanatha JK; Jones HP
    Nanomedicine (Lond); 2016; 11(5):479-94. PubMed ID: 26892440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
    Ho NI; Huis In 't Veld LGM; Raaijmakers TK; Adema GJ
    Front Immunol; 2018; 9():2874. PubMed ID: 30619259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting tumor antigens to dendritic cells using particulate carriers.
    Joshi MD; Unger WJ; Storm G; van Kooyk Y; Mastrobattista E
    J Control Release; 2012 Jul; 161(1):25-37. PubMed ID: 22580109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(gamma-glutamic acid) nanoparticles as an efficient antigen delivery and adjuvant system: potential for an AIDS vaccine.
    Wang X; Uto T; Akagi T; Akashi M; Baba M
    J Med Virol; 2008 Jan; 80(1):11-9. PubMed ID: 18041033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity.
    Hamdy S; Molavi O; Ma Z; Haddadi A; Alshamsan A; Gobti Z; Elhasi S; Samuel J; Lavasanifar A
    Vaccine; 2008 Sep; 26(39):5046-57. PubMed ID: 18680779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.